BD Expands Efforts to Combat Antimicrobial Resistance with New Diagnostic Test in Europe
27 September 2017
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the launch1 of the first automated phenotypic test to detect and classify carbapenemase-p